English 
Spanish 
Throughout May, June and July, Donations Made To Parasites Without Borders will Be Matched By The Organization And Donated To The Foundation For International Medical Relief Of Children (FIMRC).
COVID-19 Testing Strategy Simulator
There are many strategies that will reduce infection in your population. Any testing will reduce your disease burden. Using this tool to compare pooling, test accuracy, testing frequency, and costs will allow you to choose the strategy best suited to your needs and your community.
May 12, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19 | Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission | Children and COVID-19: State Date Report | Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age | FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals | Recall of B cell memory depends on relative locations of prime and boost immunization | Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial
May 5, 2022
FDA Updates on Paxlovid for Health Care Providers | SARS-CoV-2 Omicron Variant is as Deadly as Previous Waves After Adjusting for Vaccinations, Demographics, and Comorbidities | Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
April 30, 2022
Children and COVID-19: State Date Report | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalization in the UK: a prospective observational study | Moderna files for authorization of Its COVID-19 Vaccine in young children six months to under six years of age | Public health impact of covid-19 vaccines in the US: observational study | FDA approves first COVID-19 Treatment for Young Children | Veru Announces Presentation of Phase 2 Data of Sabizabulin for the Treatment of Hospitalized Severe COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome
April 23, 2022
COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region | Hospitalizations of Children Aged 5–11 Years with confirmed COVID | SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses | Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children | Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine | Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model | Intramuscular AZD7442 for Prevention of Covid-19
April 16, 2022
Children and COVID-19: State Date Report | Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance | Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination | Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization | Veru’s Novel COVID-19 Drug Candidate Reduces Deaths in Hospitalized Patients in Interim Analysis... | Comparison of Rapid Antigen Tests′ | SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies
April 9, 2022
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children | Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children | Protection by a Fourth Dose of BNT162b2 against Omicron in Israel | Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia
Situation Dashboards
World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.
